Beta-Blocking Agents and Antidiabetic Drugs

Abstract

Get full access to this article

View all access options for this article.

References

Abramson

Arky

Woeber

KA.

Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycaemia. Lancet 1966; 1: 1386–9.

Molnar

Read

Wright

FE.

Propranolol enhancement of hypoglycemic sweating. Clin Pharmacol Ther 1974; 15: 490–6.

Kaess

Kuntzen

Teckentrupp

The influence of propranolol on serum gastrin concentration and hydrochloric acid secretion in response to hypoglycemia in normal subjects. Digestion 1975; 13: 193–200.

Deacon

Barnett

Comparison of atenolol and propranolol during insulin-induced hypoglycemia. Br Med J 1976; 2: 272–3.

Newman

RJ.

Comparison of propranolol, metoprolol, and acebutolol on insulin-induced hypoglycaemia. Br Med J 1976; 2: 447–9.

Davidson

NMCD

Corrall

RJM

Shaw

TRD

Observations in man of hypoglycaemia during selective and nonselective beta-blockade. Scott Med J 1976; 22: 69–72.

Deacon

Karunanayake

Barnett

Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics. Br Med J 1977; 2: 1255–7.

Sharma

Vakil

Samuel

Comparison of penbutolol and propranolol during insulin-induced hypoglycaemia. Curr Ther Res 1979; 26: 252–9.

Kotler

Berman

Rubenstein

AH.

Hypoglycaemia precipitated by propranolol. Lancet 1966; 2: 1389–90.

10.

Wray

Sutcliffe

SBJ.

Propranolol-induced hypoglycaemia and myocardial infarction. Br Med J 1973; 2: 592.

11.

Hesse

Pedersen

JT.

Hypoglycaemia after propranolol in children. Acta Med Scand 1973; 193: 551–2.

12.

McMurtry

RJ.

Propranolol, hypoglycemia, and hypertensive crisis. Ann Intern Med 1974; 80: 669–70.

13.

Skinner

Misbin

RI.

Uses of propranolol. Ann Intern Med 1975: 293: 1205.

14.

Samii

Ciancioni

Rottembourg

Severe hypoglycemia due to beta-blocking drugs in haemodialysis patients. Lancet 1976; 1: 545–6.

15.

Jensen

Bjaeldager

Broch-Moller

Hypoglycaemia in propranolol-treated dialysis patients. Lancet 1976; 2: 368–9.

16.

Eisalo

Heino

Munter

The effect of alprenolol in elderly patients with raised blood pressure. Acta Med Scand (Suppl) 1974; 554: 23–31.

17.

Frisk-Holmberg

Jorfeldt

Juhlin-Dannfeldt

Influence of alprenolol on hemodynamic and metabolic responses to prolonged exercise in subjects with hypertension. Clin Pharmacol Ther 1977; 21: 675–84.

18.

Waal-Manning

HJ.

Atenolol and three non-selective β-blockers in hypertension. Clin Pharmacol Ther 1979; 25: 8–18.

19.

Patsch

Sailer

Untersuchung zur wirkung von pindolol auf kohlehydrat- und fettstoffwechsel bei diabetes mellitus. Int J Clin Pharmacol Biopharm 1977; 15: 394–6.

20.

Feely

Beta blockers for diabetics. Lancet 1977; 1: 950.

21.

Lloyd-Mostyn

Oram

Modification by propranolol of cardiovascular effects of induced hypoglycemia. Lancet 1975; 1: 1213–5.

22.

Smith

Lager

Beta blockade in diabetes. N Engl J Med 1978; 299: 1467–8.

23.

Beta blocker propranolol called hazardous in hypoglycemia. Diabetes Outlook 1979; 14 (July): 1–2.

24.

Van Herwaarden

CLA

Fennis

JFM

Binkhorst

Haemodynamic effects of adrenaline during treatment of hypertensive patients with propranolol and metoprolol. Eur J Clin Pharmacol 1977; 12: 397–402.

25.

Koch-Weser

Metoprolol. N Engl J Med 1979; 301: 698–703.

26.

Cairns

Marshall

AJ.

Clonidine withdrawal. Lancet 1976; 1: 368.

27.

Vernon

Sakula

Fatal rebound hypertension after abrupt withdrawal of clonidine and propranolol. Br J Clin Prac 1979; 33: 112–21.

28.

Bruce

Croley

Lee

JS.

Preoperative clonidine withdrawal syndrome. Anesthesiology 1979; 51: 90–2.

29.

Cass

Kadar

Stein

HA.

Hazards of phenylephrine topical medication in persons taking propranolol. Can Med Assoc J 1979; 120: 1261–2.

30.

Strom

Propranolol in insulin-dependent diabetes. N Engl J Med 1978; 299: 487.

31.

De Divitiis

Giordano

Gallo

Tolbutamide and propranolol. Lancet 1968; 1: 749.

32.

Scandellari

Zaccaria

De Palo

The effect of propranolol on hypoglycemia. Observations in five insulinoma patients. Diabetologia 1978; 15: 297–301.

33.

Myers

Hope-Gill

HF.

Effect of d- and dl-propranolol on glucose-stimulated insulin release. Clin Pharmacol Ther 1979; 25: 303–8.

34.

Waal-Manning

HJ.

Metabolic effects of β-adrenoreceptor blockers. Drugs 1976; 11 (Suppl 1): 121–6.

35.

Mohler

Bravo

Tarazi

RC.

Glucose intolerance during chronic β-adrenergic blockade in man (abstract). Clin Pharmacol Ther 1979; 25: 237.

36.

Ekberg

Hansson

B-G.

Glucose tolerance and insulin release in hypertensive patients treated with the cardio-selective β-receptor blocking agent metoprolol. Acta Med Scand 1977; 202: 393–7.

37.

Berchtold

Bessman

Tsao

Propranolol. Ann Intern Med 1974; 80: 119.

38.

O'Rourke

Donohue

Hayes

JA.

Beta blockers and peripheral gangrene. Med J Aust 1979: 2: 88.

39.

Frolich

Tarazi

Dustan

HP.

Peripheral arterial insufficiency: a complication of beta-adrenergic blocking therapy. JAMA 1969; 208: 2471–2.